The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...

The post Her Daughter Died After Taking a Generic Version of a Lifesaving Drug. This Is What She Wants You to Know. appeared ...

This flu season has been rough. Antivirals can help.

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...

Canada is the first country that is preparing to approve lower-cost generic weight loss drugs. Mr. Funk was the managing ...

Pharmaceutical patent protection can be extended when drug companies bring newer products to market before their first patent ...